Nektar Therapeutics (NKTR) Capital Leases (2010 - 2017)
Nektar Therapeutics (NKTR) posted Capital Leases of $1.06 million for Q2 2017, down 61.7% from $2.76 million a year earlier and down 34.4% from the prior quarter.
Powered by 
Analysis
Nektar Therapeutics (NKTR) Capital Leases (2010 - 2017) Analysis & Trends
At the end of FY2016, Nektar Therapeutics' Capital Leases came in at $2.22 million, up 107.2% from FY2015.
- Annual Capital Leases shows a five-year compound annual growth rate of -31.4% (FY2011 to FY2016).
- In prior years, Nektar Therapeutics' Capital Leases was $1.07 million in FY2015 (-74.1%), $4.14 million in FY2014 (-48.6%), $8.05 million in FY2013 (-30.7%) and $11.61 million in FY2012 (-20.4%).
- The Q2 2017 figure stands as the lowest quarterly Capital Leases in data going back to Q4 2010.
- On a year-over-year basis, Capital Leases increased in two of the last eight quarters, with an average decline of 15.4%.
- The strongest year-over-year quarter for Capital Leases in the past five years was Q4 2016, with growth of 107.2%; the weakest was Q3 2015, with a decline of 75.0%.
- According to Business Quant data, Capital Leases for the three prior quarters was $1.61 million (Q1 2017), $2.22 million (Q4 2016) and $2.14 million (Q3 2016).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Nektar Therapeutics | 1.25 Bn | -515.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2017 | 1.06 Mn |
| Mar 31, 2017 | 1.61 Mn |
| Dec 31, 2016 | 2.22 Mn |
| Sep 30, 2016 | 2.14 Mn |
| Jun 30, 2016 | 2.76 Mn |
| Mar 31, 2016 | 3.33 Mn |
| Dec 31, 2015 | 1.07 Mn |
| Sep 30, 2015 | 1.34 Mn |
| Jun 30, 2015 | 2.89 Mn |
| Mar 31, 2015 | 4.39 Mn |
| Dec 31, 2014 | 4.14 Mn |
| Sep 30, 2014 | 5.34 Mn |
| Jun 30, 2014 | 6.03 Mn |
| Mar 31, 2014 | 7.05 Mn |
| Dec 31, 2013 | 8.05 Mn |
| Sep 30, 2013 | 9.01 Mn |
| Jun 30, 2013 | 9.90 Mn |
| Mar 31, 2013 | 10.77 Mn |
| Dec 31, 2012 | 11.61 Mn |
| Sep 30, 2012 | 12.41 Mn |
API Access
Nektar Therapeutics Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=NKTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "NKTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=NKTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();